With a market cap of $154.3 billion, Boston Scientific Corporation (BSX) is a global developer, manufacturer, and marketer of ...

This was the stock's second consecutive day of losses.

Boston Scientific (NYSE:BSX) recently entered into a significant agreement with Bittium Biosignals Ltd. to supply ECG devices, valued between USD 30 to 45 million, which strengthens their cardiac ...

Outlook: Boston Scientific forecasts net sales growth of approximately 15%-17% in 2025 on a reported basis and around 12%-14% on an organic basis, compared to prior guidance of 12.5%-14.5% and 10% ...

Let’s dig into the relative performance of Boston Scientific (NYSE:BSX) and its peers as we unravel the now-completed Q1 medical devices & supplies - diversified earnings season.

For the full year, Boston Scientific sees adjusted EPS of $2.87 to $2.94 and sales up 15% to 17%, above Visible Alpha projections.

Boston Scientific has announced the appointment of Conor Russell as the new Vice President of Operations at its Galway site. Originally from Wexford, Conor joined Boston Scientific in 1999 and has ...

The Boston Globe Its stock is up 50 percent. Billion-dollar deals for breakfast. How did Boston Scientific get its mojo back? “It’s been a brick by brick, constant improvement, strengthening ...

Since arriving into Galway, Boston Scientific also expanded to Cork and Clonmel in Co Tipperary and it is now the largest life science employer in the country, employing approximately 6,500 people – ...

Boston Scientific's earnings growth may slow to the low teens, making current P/E multiples hard to justify. See why BSX stock is a Hold.

Boston Scientific first made a home in Ireland in 1994 and today stands as the largest life sciences employer in Ireland. With a workforce of more than 6,000 people across three locations at Cork, ...